DE69523745T2 - Gel zur behandlung von hauterkrankungen und zur desinfizierung von haut - Google Patents

Gel zur behandlung von hauterkrankungen und zur desinfizierung von haut

Info

Publication number
DE69523745T2
DE69523745T2 DE69523745T DE69523745T DE69523745T2 DE 69523745 T2 DE69523745 T2 DE 69523745T2 DE 69523745 T DE69523745 T DE 69523745T DE 69523745 T DE69523745 T DE 69523745T DE 69523745 T2 DE69523745 T2 DE 69523745T2
Authority
DE
Germany
Prior art keywords
gel
skin
alcohol
disinfecting
gives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69523745T
Other languages
English (en)
Other versions
DE69523745D1 (de
Inventor
Thomsen John Brown
Jens Christian Moller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BROWN THOMSEN, AASE, VILLEFRANCHE-SUR-MER, FR
Original Assignee
Thomsen John Brown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomsen John Brown filed Critical Thomsen John Brown
Publication of DE69523745D1 publication Critical patent/DE69523745D1/de
Application granted granted Critical
Publication of DE69523745T2 publication Critical patent/DE69523745T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/731—Cellulose; Quaternized cellulose derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/02—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings containing insect repellants
DE69523745T 1994-03-21 1995-03-20 Gel zur behandlung von hauterkrankungen und zur desinfizierung von haut Expired - Fee Related DE69523745T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK32594 1994-03-21
PCT/EP1995/001025 WO1995025544A1 (en) 1994-03-21 1995-03-20 Gel for treatment of skin diseases and for disinfection of the skin

Publications (2)

Publication Number Publication Date
DE69523745D1 DE69523745D1 (de) 2001-12-13
DE69523745T2 true DE69523745T2 (de) 2002-08-08

Family

ID=8092278

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69523745T Expired - Fee Related DE69523745T2 (de) 1994-03-21 1995-03-20 Gel zur behandlung von hauterkrankungen und zur desinfizierung von haut

Country Status (26)

Country Link
US (4) US5981605A (de)
EP (1) EP0751789B1 (de)
JP (1) JP3560977B2 (de)
KR (1) KR100396278B1 (de)
CN (1) CN1146725A (de)
AT (1) ATE208212T1 (de)
AU (1) AU701872B2 (de)
BR (1) BR9507164A (de)
CA (1) CA2186045A1 (de)
CZ (2) CZ286758B6 (de)
DE (1) DE69523745T2 (de)
DK (1) DK0751789T3 (de)
EE (1) EE03293B1 (de)
ES (1) ES2168111T3 (de)
FI (1) FI963696A (de)
HU (1) HUP9774641A2 (de)
LV (1) LV12951B (de)
MX (1) MX9604208A (de)
NO (1) NO314126B1 (de)
NZ (1) NZ283135A (de)
PL (1) PL179918B1 (de)
PT (1) PT751789E (de)
RU (1) RU2142273C1 (de)
SK (1) SK281575B6 (de)
UA (1) UA41989C2 (de)
WO (1) WO1995025544A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2186045A1 (en) * 1994-03-21 1995-09-28 Jens Christian Moller Gel for treatment of skin diseases and for disinfection of the skin
US6416760B2 (en) * 1995-01-26 2002-07-09 Societe L'oreal Therapeutic/cosmetic compositions comprising CGRP antagonists for treating sensitive human skin
FR2732221B1 (fr) * 1995-03-28 1997-04-25 Oreal Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue
DE19624508A1 (de) * 1996-06-19 1998-01-08 Guetter Hans Peter Dr Verwendung von C¶3¶-C¶4¶-Alkoholen zur Behandlung von Herpeserkrankungen
AU729078B2 (en) 1996-06-24 2001-01-25 Bio-Safe Enterprises, Inc. Antibacterial composition
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
EP1295893A4 (de) * 2000-05-31 2005-10-26 Japan Science & Tech Agency Ginsenoside zur förderung der hautgeweberegeneration
AUPR028000A0 (en) * 2000-09-21 2000-10-12 Hair Advisory Centre Pty. Ltd. Ectoparasite formulation
US6581775B1 (en) * 2001-08-10 2003-06-24 Garo Hagopian Method of external genital cleansing and prophylactic kit
CA2421026C (en) * 2001-10-16 2005-02-15 Avanir Pharmaceuticals Viral inhibition by n-docosanol
US20050042240A1 (en) * 2002-01-28 2005-02-24 Utterberg David S. High viscosity antibacterials
DE10219597A1 (de) * 2002-05-02 2003-11-20 Wella Ag Wasserfreie Haarstylinggele
JPWO2003105903A1 (ja) * 2002-06-18 2005-10-13 ポーラ化成工業株式会社 抗真菌医薬組成物
US20040191286A1 (en) * 2003-03-24 2004-09-30 Bijan Safai Head lice medication and treatment
GB0318160D0 (en) * 2003-08-02 2003-09-03 Ssl Int Plc Parasiticidal composition
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US20060024372A1 (en) * 2004-07-29 2006-02-02 Utterberg David S High viscosity antibacterials
US7268165B2 (en) * 2004-08-20 2007-09-11 Steris Inc. Enhanced activity alcohol-based antimicrobial compositions
US20070116749A1 (en) * 2005-11-21 2007-05-24 Grossman Leonard D Method for treatment of cellulitis
DE102005059742A1 (de) 2005-12-13 2007-06-14 Beiersdorf Ag Transparentes Sonnenschutzmittel
HUE027395T2 (hu) 2006-07-21 2016-10-28 Biodelivery Sciences Int Inc Eszközök nyálkahártyán keresztül történõ bejuttatására, javított felszívódással
CA2677394C (en) 2006-10-23 2013-06-25 Ecolab Inc. Skin-compatible virucidal composition
US20100063004A1 (en) * 2006-12-04 2010-03-11 Ranjan Ray Chaudhuri Topical pharmaceutical composition
JP5028131B2 (ja) * 2007-04-13 2012-09-19 花王株式会社 ゲル化剤
WO2008137747A1 (en) 2007-05-02 2008-11-13 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
US20100247564A1 (en) * 2007-05-24 2010-09-30 David Yue-Wei Lee Methods and compositions for the use of sargassum fusiforme for the inhibition of hiv-1 infection
DE102008028993A1 (de) * 2007-06-29 2009-01-08 Bode Chemie Gmbh & Co. Kg Verwendung eines alkoholischen Desinfektionsmittels zur Schnelldesinfektion
EA013233B1 (ru) * 2008-06-12 2010-04-30 Иностранное Частное Унитарное Производственно-Торговое Предприятие "Инкраслав" Фирмы "Вера, О.О.О. Прешов" Антисептическая композиция для дезинфекции кожных покровов, способ ее приготовления и полупродукт для ее приготовления
US20100158821A1 (en) * 2008-12-22 2010-06-24 Eastman Chemical Company Antimicrobial agents, compositions and products containing the same, and methods of using the compositions and products
US8106111B2 (en) 2009-05-15 2012-01-31 Eastman Chemical Company Antimicrobial effect of cycloaliphatic diol antimicrobial agents in coating compositions
US9554994B2 (en) * 2009-12-16 2017-01-31 Ecolab Usa Inc. Composition in form of a gel for the virucidal disinfection of mammalian skin
US10383894B2 (en) * 2010-03-17 2019-08-20 Lutran Industries, Inc. Human medicinal treatment using salt of peroxymonosulfuric acid
GB201010256D0 (en) * 2010-06-18 2010-07-21 Reckitt Benckiser Inc Germicidal topical compositions
FR2976808B1 (fr) * 2011-06-22 2013-06-28 Urgo Lab Composition filmogene et son utilisation pour le traitement de l'herpes
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US10071233B2 (en) * 2015-05-22 2018-09-11 L'oreal Point applicator for treating skin conditions
US10334853B2 (en) * 2016-03-29 2019-07-02 Larada Sciences Compositions and methods for treating ectoparasite infestation

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2054989A (en) * 1933-12-30 1936-09-22 Us Ind Alcohol Co Compositions for application to the human skin
DE1000367B (de) 1952-11-17 1957-01-10 Mo Och Domsjoe Ab Verfahren zur Herstellung von in Wasser und/oder Alkali loeslichen Celluloseaethern
US3016328A (en) * 1961-01-03 1962-01-09 Ethicon Inc Dialdehyde alcoholic sporicidal composition
US4019521A (en) * 1973-06-06 1977-04-26 Philip Morris Incorporated Smokable material and method for preparing same
US3876771A (en) * 1973-09-04 1975-04-08 Hallister Inc Skin protective gel containing polyvinyl methylether or monoisopropyl ester of polyvinyl methylether maleic acid
GB1582744A (en) * 1976-06-04 1981-01-14 Gruenenthal Gmbh 7h-thiazolo (and 1,3,4-thiadiazolo-)(3,2-a) pyrimidin-7-one-5-carboxylic acids derivatives and medicaments therof
SE418686B (sv) * 1978-03-31 1981-06-22 Landstingens Inkopscentral Vattenbaserad salva for huddesinfektion innehallande alkohol som desinfektionsmedel
GB1593097A (en) * 1978-05-26 1981-07-15 Fisons Ltd Pharmaceutical compositions containing a bischromone
US4256872A (en) * 1978-09-26 1981-03-17 Occidental Research Corporation Process for preparing layered organophosphorus inorganic polymers
US4247547A (en) * 1979-03-19 1981-01-27 Johnson & Johnson Tretinoin in a gel vehicle for acne treatment
US4590214A (en) * 1980-04-14 1986-05-20 Sepreh, Inc. Method of treatment for herpes
JPS5855411A (ja) * 1981-09-28 1983-04-01 Nitto Electric Ind Co Ltd 基剤組成物および外用医薬組成物
US4431633A (en) * 1982-04-27 1984-02-14 Merck & Co., Inc. Influenza vaccine
DE3430709A1 (de) * 1984-08-21 1986-03-06 Krüger GmbH & Co KG, 5060 Bergisch Gladbach Viruzides mittel
US5288486A (en) * 1985-10-28 1994-02-22 Calgon Corporation Alcohol-based antimicrobial compositions
US4671955A (en) * 1986-03-31 1987-06-09 Victor Palinczar Waterproof sunscreen compositions
FR2613621B1 (fr) * 1987-04-10 1990-06-29 Roussel Uclaf Butyl hydroxyanisoles pour utilisation dans le traitement prophylactique des maladies a retro-virus comme agents modificateurs de l'infectivite des retro-virus et produits anti-infectants
US5013545A (en) * 1987-12-09 1991-05-07 Thames Pharmacal Co., Inc. Aqueous gels containing topical medicaments
US5098717A (en) * 1987-12-09 1992-03-24 Thames Pharmacal Co., Inc. Method of treatment for pruritus
CA1337329C (en) * 1989-01-31 1995-10-17 Paul L. Simmons Biodegradable disinfectant
US4923875A (en) * 1989-07-10 1990-05-08 Baker Cummins Pharmaceuticals, Inc. Method for treatment of mast cell-mediated dermatologic disorders
US5331012A (en) * 1990-07-30 1994-07-19 Riddick Kenneth B Topical pharmaceutical preparation for fever blisters and other viral infections and method of use
SE9003712L (sv) * 1990-11-22 1992-01-07 Kabi Pharmacia Ab Gelbildande flytande baerarkomposition samt anvaendning daerav i farmaceutiska kompositioner
ATE152356T1 (de) * 1991-06-20 1997-05-15 Viro Tex Corp Topisches präparat zur besseren heilung von herpesverletzungen
US5376366A (en) 1992-11-12 1994-12-27 John Petchul Composition and process for forming isopropyl alcohol gel with water-soluble vinyl polymer neutralizing agent
CA2186045A1 (en) * 1994-03-21 1995-09-28 Jens Christian Moller Gel for treatment of skin diseases and for disinfection of the skin
US5665751A (en) * 1995-06-07 1997-09-09 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of cancers

Also Published As

Publication number Publication date
CZ286758B6 (en) 2000-06-14
WO1995025544A1 (en) 1995-09-28
EE03293B1 (et) 2000-10-16
FI963696A0 (fi) 1996-09-18
US20040054015A1 (en) 2004-03-18
US6342537B1 (en) 2002-01-29
PT751789E (pt) 2002-04-29
LV12951B (en) 2003-05-20
AU701872B2 (en) 1999-02-11
US5981605A (en) 1999-11-09
BR9507164A (pt) 1997-09-09
ES2168111T3 (es) 2002-06-01
NO963971D0 (no) 1996-09-20
NZ283135A (en) 2004-12-24
HUP9774641A2 (en) 1997-01-28
PL179918B1 (pl) 2000-11-30
ATE208212T1 (de) 2001-11-15
MX9604208A (es) 1998-05-31
FI963696A (fi) 1996-11-07
RU2142273C1 (ru) 1999-12-10
SK281575B6 (sk) 2001-05-10
UA41989C2 (uk) 2001-10-15
DE69523745D1 (de) 2001-12-13
NO314126B1 (no) 2003-02-03
HU9602583D0 (en) 1996-11-28
US20020086905A1 (en) 2002-07-04
NO963971L (no) 1996-11-19
DK0751789T3 (da) 2003-09-08
CZ272396A3 (en) 1997-06-11
KR100396278B1 (ko) 2003-11-28
JP3560977B2 (ja) 2004-09-02
CZ288150B6 (en) 2001-05-16
EP0751789A1 (de) 1997-01-08
CN1146725A (zh) 1997-04-02
SK119496A3 (en) 1997-06-04
CA2186045A1 (en) 1995-09-28
JPH09510468A (ja) 1997-10-21
PL316651A1 (en) 1997-02-03
EP0751789B1 (de) 2001-11-07
AU2109995A (en) 1995-10-09

Similar Documents

Publication Publication Date Title
DE69523745D1 (de) Gel zur behandlung von hauterkrankungen und zur desinfizierung von haut
DE69733132D1 (de) Verwendung von antioxidantien zur behandlung cholestatischer lebererkrankungen
DE59409832D1 (de) Pflaster zur behandlung von nagelmykosen
DE60117043D1 (de) Behandlung von mukositis
CY1105125T1 (el) Χρηση αναστολεων ακετυλοχολινεστepασης για την παρασκευη φαρμακευτικων συνθεσεων για τη θepαπευτικη αντιμετωπιση συνδρομων λειτουργικων και/ή οργανικων πονων
BR0116832A (pt) Produto desodorante, método cosmético e método de fabricação de composição desodorante
BRPI9908182B8 (pt) composições de proteína de matriz para cura de feridas
ATE285219T1 (de) Rekombinante haarbehandlungsmittel
ES2148469T3 (es) N-hidroxipiperidinas como agentes de barrido de radicales superoxido.
DE69310528D1 (de) Verwendung von parathormone, seinen biologisch aktiven fragmenten oder von verwandten peptiden zur behandlung von schwangerschaft
ATE222101T1 (de) Verwendung von selegilin oder desmethylselegilin zur behandlung von wunden, verbrennungen und hautschäden
TR200100637T2 (tr) Yeni doğal ürün türevleri
DE69531150D1 (de) Verwendung von biopolymeren zur behandlung der muskeln
ES2110057T3 (es) Composicion medicinal que contiene tcf-ii.
DE69424679T2 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
HUP9900007A2 (hu) Készítmény baromfialom kezelésére
ATE137967T1 (de) Verwendung von ketorolac zur behandlung von periodontitis
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
ATE200624T1 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
HUP0101602A2 (hu) Termékenységet javító készítmény, és annak alkalmazása
DE59709081D1 (de) Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung und Prävention der Alzheimer'schen Krankheit
HUP9800715A2 (hu) Seb- és nyálkahártya-antiszeptikum
DE60113895D1 (de) Verwendung von Tiludronsäure beim Geflügel zur Herstellung eines Arzneimittels zur Prophylaxe und Behandlung von Osteoporose
UA39988C2 (uk) Антимікробний засіб" асперсепт" та спосіб лікування та профілактики інфекційних уражень шкіри за допомогою цього засобу

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BROWN THOMSEN, AASE, VILLEFRANCHE-SUR-MER, FR

8339 Ceased/non-payment of the annual fee